Local Marketing and Sales Network Development Focused on China and Vietnam
First written in FY2016-Q3. 17 of 34 entries say "Advanced", first in FY2017-Q3. Latest entry: 2026-10-15.
The whole theme swung hardest in 2020: 5 of 24 companies on the "Worse" side.
12 other companies' latest entry also says "Advanced".
- 2026-10-15AdvancedEarnings
「Orders resumed from numerous customers, including distributors and end users, as a result of vigorous activities by the Chinese sales subsidiary and other factors, and the recovery in business performance is progressing beyond expectations.」
中国販売子会社の活動が、多数の顧客からの注文再開と販売回復として実績化している。 - FY2026-H1AdvancedAnnual report
「Orders resumed from numerous customers, including distributors and end users, as a result of vigorous activities by the Chinese sales subsidiary and other factors, and the recovery in business performance is progressing beyond expectations.」
The company states that activities by its Chinese sales subsidiary led to the resumption of customer orders, including orders for diamond burs, and to a better-than-expected recovery in business performance. - FY2025AdvancedAnnual report
「Effective 1 September 2025, the existing Malaysian sales subsidiary was designated as the regional headquarters for Asia, MANI ASIA SDN. BHD., and began operations.」
The Malaysian sales subsidiary expanded its role from a single sales base to the regional headquarters for Asia and began operations on 1 September 2025. - FY2025-H1AdvancedAnnual report
「To expand its global business, the company established a new sales subsidiary, MANI MEDICAL AMERICA, INC., in September 2024 and is proceeding with hiring personnel, developing new distributors and establishing a distribution network. It aims to promote locally focused sales and expand its business in North America.」
The company states that, following the establishment of its U.S. sales subsidiary, it has entered the phase of hiring personnel, developing distributors and establishing a distribution network. - FY2024AdvancedAnnual report
「In the advanced markets of Europe and the United States, the company established a new U.S.-based sales base, MANI MEDICAL AMERICA, INC., in September 2024. It will promote locally focused sales in medically advanced countries.」
In addition to its existing distribution networks in China, Vietnam, India and Malaysia, the company established a U.S. sales subsidiary in September 2024, putting locally focused sales in North America into practice. - FY2024-Q3AdvancedAnnual report
「At its board meeting on 26 June 2024, the company resolved to establish a new sales subsidiary in the United States. It will promote locally focused sales in medically advanced countries and expand its business in the North American market.」
In addition to distribution networks in China, Vietnam, India and Malaysia, the company resolved at a board meeting to establish a U.S. sales subsidiary, putting locally focused sales in the North American market into practice. - FY2024-Q2AdvancedAnnual report
「MANI MEDICAL DEVICE MALAYSIA SDN. BHD., a sales subsidiary established in Malaysia as a new base, began full-scale sales activities in November 2023. Going forward, the company will actively pursue sales and marketing activities for dental-related and surgical-related products, targeting emerging countries in Southeast Asia.」
The Malaysian sales subsidiary progressed from preparing for full-scale operations through the previous quarter to starting sales activities in November 2023. Sales and marketing activities targeting emerging Southeast Asian countries are also continuing. - FY2024-Q1AdvancedAnnual report
「MANI MEDICAL DEVICE MALAYSIA SDN. BHD., a sales subsidiary established in Malaysia as a new base, was ready in November 2023 to begin full-scale operations. Going forward, the company will actively pursue sales and marketing activities for dental-related and surgical-related products, targeting emerging countries in Southeast Asia.」
The company states that its Malaysian sales subsidiary was ready in November 2023 to begin full-scale operations, and that it has moved to the next stage of developing sales and marketing activities for emerging Southeast Asian countries. - FY2023RestatedAnnual report
「Through MANI MEDICAL DEVICE MALAYSIA SDN. BHD., a sales subsidiary newly established in Malaysia in June 2023, we will promote locally focused marketing activities, identify local user needs and work to expand the distribution network.」
The company maintains its policy of locally focused sales in China, India, ASEAN and other markets, and describes marketing in Southeast Asia and distribution-network expansion through its Malaysian sales subsidiary. - FY2023-Q3AdvancedAnnual report
「As part of its global marketing initiatives, the company established a new sales subsidiary in Malaysia in June 2023, with the aim of conducting marketing activities for Southeast Asian countries and expanding sales.」
In addition to distribution networks in China, Vietnam and India, the company established a Malaysian sales subsidiary in June 2023, adding a marketing base for Southeast Asian countries. - FY2023-Q2AdvancedAnnual report
「Orders for eyeless needles continued to increase in Asia, particularly China, as well as North America and Europe, resulting in substantial increases in revenue and profit.」
In connection with distribution networks in emerging markets and overseas, orders for eyeless needles increased in Asia, particularly China, as well as North America and Europe. Revenue was ¥4,154 million, up 45.4% year on year. - FY2022-Q3AdvancedAnnual report
「Revenue was ¥14,830 million, up 14.6% year on year, owing to increased sales in Asia, a recovery in demand in Europe, and the foreign-exchange impact of the weaker yen.」
The company states that increased sales in Asia and a recovery in European demand resulted in consolidated revenue growth of 14.6% year on year. - FY2022-Q2AdvancedAnnual report
「Revenue was ¥9,651 million, up 16.2% year on year, owing to increased sales in Asia, particularly China, and a recovery in demand in Europe.」
Sales increased in Asia, led by China, and demand in Europe also recovered, resulting in consolidated revenue growth of 16.2% year on year. - FY2022-Q1AdvancedAnnual report
「Sales rose in China and India, while sales in South Korea remained solid, among other factors. Revenue was ¥2,083 million, up 10.3% year on year.」
In connection with efforts to develop distribution networks in emerging markets, the company reported increased sales in China and India and solid sales in South Korea, along with 10.3% year-on-year growth in dental-related products. - FY2021-Q3RestatedAnnual report
「We have worked to strengthen marketing by holding Web-based seminars for physicians and introducing products to customers, primarily in emerging markets where demand is expected to expand.」
The company continues to strengthen marketing in emerging markets through Web seminars and product introductions to customers. - FY2021-Q2RestatedAnnual report
「We aim to strengthen marketing by actively holding Web-based seminars for physicians and introducing products to dealers, particularly at overseas sales bases where demand is expected to expand. Dental-related products posted higher sales, driven by China, where the market recovered relatively quickly and sales activities are gradually resuming as usual.」
The company continues to hold Web seminars at overseas sales bases, introduce products to dealers, and strengthen marketing, particularly in China. Sales of dental-related products in China drove revenue growth. - FY2021-Q1AdvancedAnnual report
「We aim to strengthen marketing by actively holding Web-based seminars for physicians and introducing products to dealers, particularly at overseas sales bases where demand is expected to expand.」
In addition to developing existing local sales bases and distribution networks, the company is holding Web-based seminars for physicians and introducing products to dealers, thereby putting specific marketing measures in place under COVID-19. - FY2020AdvancedAnnual report
「In addition, while marketing activities are constrained by the impact of COVID-19, we will seek to establish a new sales model, including developing new customers through web seminars conducted by KOLs (Key Opinion Leaders).」
In addition to local sales bases and sales-network development, the statement identifies developing new customers through web seminars conducted by KOLs as a new initiative amid COVID-19. - FY2020-Q3SoftenedAnnual report
「Against this backdrop, our Group continued working to identify user needs and develop our sales network in emerging markets where demand is expected to continue growing. However, marketing activities were restricted by the impact of COVID-19, and the number of surgical procedures worldwide and other activities was limited, resulting in lower sales across all segments, including surgical-related, eyeless-needle-related and dental-related products.」
The statement notes that efforts to identify user needs and develop the sales network in emerging markets continued, but marketing activities were restricted by COVID-19, resulting in lower sales across all segments. - FY2020-Q2RestatedAnnual report
「Against this backdrop, in emerging markets where demand is expected to continue growing, our Group strengthened marketing centered on local sales bases and worked to identify user needs in each country and develop our sales network, but」
The statement notes that marketing centered on local sales bases in emerging markets, user-needs identification and sales-network development continued. - FY2020-Q1RestatedAnnual report
「Against this backdrop, in emerging markets where demand is expected to continue growing, our Group strengthened marketing centered on local sales bases and worked to identify user needs in each country and develop our sales network.」
The statement notes that marketing centered on local sales bases in emerging markets, user-needs identification and sales-network development continued. - FY2019RaisedAnnual report
「To accelerate these activities, we will proceed with preparations to establish a fourth sales base following Vietnam, China and India.」
In addition to the sales bases in China, Vietnam and India, the statement explicitly identifies preparations to establish a fourth sales base, expanding the scope of the sales network. - FY2019-Q3RestatedAnnual report
「In emerging markets where demand is expected to continue growing, we strengthened marketing centered on local sales bases and worked to identify user needs in each country and develop our sales network. As a result, we were able to increase sales of surgical-related and eyeless-needle-related products.」
The statement notes that marketing, customer-needs identification and sales-network development centered on local sales bases in emerging markets continued, resulting in higher sales of surgical-related and eyeless-needle-related products. - FY2019-Q2RestatedAnnual report
「Against this backdrop, in emerging markets where demand is expected to continue growing, our Group strengthened marketing centered on local sales bases and worked to identify user needs in each country and develop our sales network. As a result, we were able to increase sales of surgical-related and eyeless-needle-related products.」
The statement notes that marketing, customer-needs identification and sales-network development centered on local sales bases in emerging markets continued, resulting in higher sales of surgical-related and eyeless-needle-related products. - FY2018RestatedAnnual report
「Against this backdrop, in emerging markets where demand is expected to continue growing, our Group strengthened marketing centered on local sales bases in China, Vietnam and India and worked to identify user needs in each country and develop our sales network. As a result, we were able to significantly increase sales of surgical-related products and eyeless-needle-related products.」
The statement notes that marketing, customer-needs identification and sales-network development centered on local sales bases in China, Vietnam and India continued, resulting in higher sales of surgical-related and eyeless-needle-related products. - FY2018-Q3RestatedAnnual report
「In emerging markets where demand is expected to continue growing, we strengthened marketing centered on local sales bases and worked to identify user needs and develop our sales network. As a result, we were able to significantly increase sales in all segments.」
The statement notes that marketing centered on local sales bases in emerging markets, customer-needs identification and sales-network development continued, resulting in a significant increase in sales across all segments. These are continuations of initiatives through the previous quarter. - FY2018-Q2AdvancedAnnual report
「Against this backdrop, in emerging markets where demand is expected to continue growing, our Group strengthened marketing centered on local sales bases and worked to identify user needs and develop our sales network. As a result, we were able to significantly increase sales across all segments.」
The statement notes that efforts to strengthen marketing and develop the sales network centered on local sales bases continued, resulting in a significant increase in sales across all segments. - FY2018-Q1RestatedAnnual report
「In emerging markets where demand is expected to continue growing, we strengthened marketing centered on local sales bases and worked to identify user needs and develop our sales network. As a result, sales in the Asian region remained strong.」
The statement notes that marketing centered on local sales bases, customer-needs identification and sales-network development continued in emerging markets, resulting in strong sales in Asia. - FY2017RestatedAnnual report
「As a result of strengthening local marketing, primarily through our sales bases in China, 馬尼(北京)貿易有限公司, and Vietnam, MANI MEDICAL HANOI CO., LTD., and working to identify user needs and develop our sales network, we were able to significantly increase sales in China of both dental-related and surgical-related products. In addition, in India's rapidly growing market, we newly established a sales base, MANI MEDICAL INDIA PRIVATE LIMITED, and worked to build a foundation for expanding sales in the future.」
Activities centered on China and Vietnam and expansion into emerging markets through the Indian sales base are continuing. The statement describes higher sales of both dental-related and surgical-related products in China and the groundwork for expanding sales in India, but these are continuations of initiatives described through the previous quarter. - FY2017-Q3AdvancedAnnual report
「To expand sales in India's rapidly growing market, we newly established a sales base, MANI MEDICAL INDIA PRIVATE LIMITED.」
In addition to the emerging-market sales network centered on China and Vietnam, a sales and marketing base was actually established in India. - FY2017-Q2RestatedAnnual report
「Against this backdrop, in emerging markets where demand is expected to continue growing, our Group strengthened local marketing, primarily through our sales bases in China, 馬尼(北京)貿易有限公司, and Vietnam, MANI MEDICAL HANOI CO., LTD., while working to identify user needs and develop our sales network. As a result, we were able to significantly increase sales of dental-related products in China.」
The statement notes that local marketing, customer-needs identification and sales-network development centered on the sales bases in China and Vietnam continued, resulting in a significant increase in sales of dental-related products in China. - FY2017-Q1RestatedAnnual report
「Against this backdrop, in emerging markets where demand is expected to continue growing, our Group strengthened local marketing, primarily through our sales bases in China, 馬尼(北京)貿易有限公司, and Vietnam, MANI MEDICAL HANOI CO., LTD., while working to identify user needs and develop our sales network. As a result, sales of dental-related products in China remained strong.」
The statement notes that local marketing, customer-needs identification and sales-network development centered on the sales bases in China and Vietnam continued, resulting in strong sales of dental-related products in China. - FY2016RaisedAnnual report
「Our immediate targets in emerging markets are the large, rapidly growing Asian markets of China, India and ASEAN. We will promote locally rooted sales and marketing activities through our Vietnamese sales subsidiary, MANI MEDICAL HANOI CO., LTD., and our Chinese sales subsidiary, 馬尼（北京）貿易有限公司, with the aim of acquiring segments we have not previously been able to reach. Going forward, we will gradually expand the products we handle and step up these activities, while also actively expanding into India, ASEAN and other markets.」
The statement explicitly expands the scope of its activities beyond China and Vietnam to India and ASEAN, and also identifies an expansion of the product range. - FY2016-Q3First statedAnnual report
「In emerging markets, where demand is expected to continue expanding, we strengthened local marketing activities centered on the Chinese sales base, 馬尼(北京)貿易有限公司, and the Vietnamese sales base, MANI MEDICAL HANOI CO., LTD., while working to understand user needs and develop the sales network.」
Uses sales bases in China and Vietnam to strengthen local marketing, understand customer needs and develop the sales network.